What is the product/service about?
The product is an all-in-one platform for radiology,capable of extracting massive amounts of quantitative data from the images. The data is integrated in the radiology report of the future, comparing the imaging biomarkers (variables measured in the images) with normative data, similarly to a blood
test report, but obtained from imaging.
In the case of prostate, the product will improve through lnnowide project support, it offers a virtual biopsy of the prostate by the multi-parametri c MRI analysis. The product is offered as a service. As of today it is cleared by FDA as a PACS device but not as a Computer Aided Detection tool (CAD). Our plan is to gather biopsy-proven information from to clear it as a CAD as well thanks to innowide project.
QUIBIM Precision® image analysis platform has received CE Mark certification as a Class Ila Medical Device and 51Ok certificate from FDA,including its imaging biomarker analysis algorithms, the zero footprint DICOM viewer and its platform hosting these components and medical imaging data.
Where did the project idea come from?
We saw an opportunity on providing an advanced solution for prostate MRI diagnosis when there was a publication by the American College of Radiology providing evidence on the benefit of performing a pre¬ biopsy prostate MRI,decreasi ng number of cylinders,the number of unnecessary biopsies and increasing sensitivity as compared to standard procedures (digital rectal examination,ultrasound and blind biopsy).
Why did you select that specific target country?
The roadmap of the company includes direct sales in US and the market of prostate cancer assessment is very high. We were building a partnership with a hospital in NY that was aligned with our proposal to lnnowide project.
Who are your partners in the target country?
Hospital: Stony Brook Medicine in New York. We work on product validation studies.
What is your long term vision for your company working in your chosen partner country?
To lead the market of Al-based prostate MRI diagnosis.
What impact do you believe INNOWWIDE will have on your company?
INNOWIDE is an enabler for our success in US. It wouldn’t have been possible without innowide to get to US as fast and with a validation study and market analysis in place.
Can you offer any advice or guidance to others looking to apply for INNOWWIDE grants?